Plunkett Research Online: Cleveland BioLabs Inc

CLEVELAND BIOLABS INC (CBLI:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Cleveland BioLabs, Inc. is a drug discovery and development company leveraging its proprietary discoveries around programmed cell death to develop treatments for cancer and protection of normal tissues from radiation and other stresses. The company’s pipeline includes products from two main familie.....



Cleveland BioLabs Inc
Ticker: CBLI
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 716 849-6810
Fax: 716 849-6820
Address: 73 High Street
Buffalo, NY 14203 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceuticals
Contacts Description

Yakov Kogan CEO/CFO/Secretary
Andrei Gudkov Chief Scientific Officer
See More
Cleveland BioLabs, Inc. is a drug discovery and development company leveraging its proprietary discoveries around programmed cell death to develop treatments for cancer and protection of normal tissues from radiation and other stresses. The company’s pipeline includes products from two main familie.....See More See More

Auditor: Meaden & Moore, Ltd.
Legal Advisor: Mintz, Levin, Cohen, Ferris, Glovsky and Popeo, P.C.
Table could not be created because no data was found
Brands, Divisions and Affiliates Top Salaries
Other Thoughts Corporate Culture

Apparent Female Officers or Directors: